Nazanin Azarinejad Mohammadi,Philip Kiær Ahring,Vivian Wan Yu Liao,Han Chow Chua,Sebastián Ortiz de la Rosa,Katrine Marie Johannesen,Yael Michaeli-Yossef,Aline Vincent-Devulder,Catherine Meridda,Ange-Line Bruel,Alessandra Rossi,Chirag Patel,Joerg Klepper,Paolo Bonanni,Sara Minghetti,Marina Trivisano,Nicola Specchio,David Amor,Stéphane Auvin,Sarah Baer,Pierre Meyer,Mathieu Milh,Vincenzo Salpietro,Reza Maroofian,Johannes R. Lemke,Sarah Weckhuysen,Palle Christophersen,Guido Rubboli,Mary Chebib,Anders A. Jensen,Nathan L. Absalom,Rikke Steensbjerre Møller

Abstract:Summary Background Variants in GABRB 2, encoding the β2 subunit of the γ-aminobutyric acid type A (GABA A ) receptor, can result in a diverse range of conditions, ranging from febrile seizures to severe developmental and epileptic encephalopathies. However, the mechanisms underlying the risk of developing milder vs more severe forms of disorder remain unclear. In this study, we conducted a comprehensive genotype–phenotype correlation analysis in a cohort of individuals with GABRB 2 variants. Methods Genetic and electroclinical data of 42 individuals harbouring 26 different GABRB 2 variants were collected and accompanied by electrophysiological analysis of the effects of the variants on receptor function. Findings Electrophysiological assessments of α1β2γ2 receptors revealed that 25/26 variants caused dysfunction to core receptor properties such as GABA sensitivity. Of these, 17 resulted in gain-of-function (GOF) while eight yielded loss-of-function traits (LOF). Genotype-phenotype correlation analysis revealed that individuals harbouring GOF variants suffered from severe developmental delay/intellectual disability (DD/ID, 74%), movement disorders such as dystonia or dyskinesia (59%), microcephaly (50%) and high risk of early mortality (26%). Conversely, LOF variants were associated with milder disease manifestations. Individuals with these variants typically exhibited fever-triggered seizures (92%), milder degrees of DD/ID (85%), and maintained ambulatory function (85%). Notably, severe movement disorders or microcephaly were not reported in individuals with loss-of-function variants. Interpretation The data reveals that genetic variants in GABRB 2 can lead to both gain and loss-of-function, and this divergence is correlated with distinct disease manifestations. Utilising this information, we constructed a diagnostic flowchart that aids in predicting the pathogenicity of recently identified variants by considering clinical phenotypes. Funding This work was funded by the Australian National Health & Medical Research Council , the Novo Nordisk Foundation and The Lundbeck Foundation .

FOXG1 variants can be associated with milder phenotypes than congenital Rett syndrome with unassisted walking and language development

Novel FOXG1 Mutations in Chinese Patients with Rett Syndrome or Rett-like Mental Retardation.

Paving Therapeutic Avenues for FOXG1 Syndrome: Untangling Genotypes and Phenotypes from a Molecular Perspective

Identification of a de novo mutation of the FOXG1 gene and comprehensive analysis for molecular factors in Chinese FOXG1-related encephalopathies

AAV-mediated FOXG1 gene editing in human Rett primary cells

Identification of a Novel FOXP1 Variant in a Patient with Hypotonia, Intellectual Disability, and Severe Speech Impairment

Parental mosaicism rather than de novo variants in FOXG1‐related syndrome and TUBA1A‐associated Tubulinopathy: Familial case reports

PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice

Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes

FOXI3 pathogenic variants cause one form of craniofacial microsomia

FOXG1 Drives Transcriptomic Networks to Specify Principal Neuron Subtypes During the Development of the Medial Pallium

Utilization of next-generation sequencing to define the role of heterozygous FOXN1 variants in immunodeficiency

Rett and Rett-like syndrome: Expanding the genetic spectrum to KIF1A and GRIN1 gene.

Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants

A Novel Variant in FOXC1 Associated with Atypical Axenfeld-Rieger Syndrome

FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders

Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits

Conditional Deletion of Foxg1 Delayed Myelination during Early Postnatal Brain Development

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt

Pathogenic Missense Mutation Pattern of Forkhead Box Genes in Neurodevelopmental Disorders